Osteoarticular Infections in MIMIC-IV, A Clinical and Microbiological Analysis

Mohammadreza Azarpira1, Jean-Claude Gascoin1

  • 1Centre Hospitalier Intercommunal de Meulan-les-Mureaux, Yvelins, France.

Insights

This study analyzed osteoarticular infections (OAIs) using the MIMIC-IV database. Findings reveal patterns in inflammatory markers and identify specific risks associated with comorbidities like immune deficiency and diabetes.

Area of Science:

  • Infectious Diseases
  • Medical Informatics
  • Clinical Epidemiology

Background:

  • Osteoarticular infections (OAIs) present significant clinical challenges, exacerbated by increasing antimicrobial resistance.
  • Effective management requires understanding inflammatory marker (IM) utilization and comorbidity-specific risks for multidrug-resistant organisms (MDROs).

Purpose of the Study:

  • To characterize IM ordering patterns in OAIs using a structured informatics workflow.
  • To assess comorbidity-specific infection risks and identify prevalent MDROs.
  • To inform the development of diagnostic and therapeutic decision support tools for OAIs.

Main Methods:

  • Utilized the MIMIC-IV database for a retrospective analysis.
  • Applied a structured informatics workflow to analyze IM ordering, infection risks, and MDRO identification.
  • Examined the association between specific comorbidities (immune deficiency, diabetes, sickle cell disease) and OAI prevalence and pathogen profiles.

Main Results:

  • Observed overuse of white blood cell (WBC) counts as an inflammatory marker.
  • Identified distinct pathogen profiles associated with different comorbidity groups.
  • Found increased OAI rates in patients with immune deficiency and diabetes, but not sickle cell disease.

Conclusions:

  • Inflammatory marker ordering in OAIs may not be optimal, with potential for overuse of certain tests like WBC counts.
  • Comorbidities significantly influence OAI risk and pathogen characteristics, necessitating tailored diagnostic and treatment strategies.
  • Informatics-driven analysis of large datasets like MIMIC-IV can reveal critical insights for improving OAI management and combating antimicrobial resistance.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...